How does neurokinin 3 receptor agonism affect pathological and cognitive impairments in an Alzheimer's disease-like rat model?
dc.authorid | Raviye Özen Koca: 0000-0001-6295-5548 | en_US |
dc.authorid | Zülfikare Işık Solak Görmüş: 0000-0001-6762-6225 | en_US |
dc.authorid | Hatice Solak: 0000-0002-3554-3051 | en_US |
dc.authorid | Aynur Koç: 0000-0001-5532-3737 | en_US |
dc.authorid | İbrahim Kılınç: 0000-0002-7729-7557 | en_US |
dc.authorid | Mehmet Sinan İyisoy: 0000-0001-5895-9984 | en_US |
dc.authorid | Selim Kutlu: 0000-0001-9257-4797 | en_US |
dc.contributor.author | Özen Koca, Raviye | |
dc.contributor.author | Solak Görmüş, Zülfikare Işık | |
dc.contributor.author | Solak, Hatice | |
dc.contributor.author | Koç, Aynur | |
dc.contributor.author | Kılınç, İbrahim | |
dc.contributor.author | İyisoy, Mehmet Sinan | |
dc.contributor.author | Kutlu, Selim | |
dc.date.accessioned | 2023-04-07T10:53:27Z | |
dc.date.available | 2023-04-07T10:53:27Z | |
dc.date.issued | 2023 | en_US |
dc.department | NEÜ, Meram Tıp Fakültesi, Temel Tıp Bilimleri Bölümü, Fizyoloji Anabilim Dalı | en_US |
dc.department | NEÜ, Meram Tıp Fakültesi, Temel Tıp Bilimleri Bölümü, Tıbbi Biyokimya Anabilim Dalı | en_US |
dc.department | NEÜ, Meram Tıp Fakültesi, Temel Tıp Bilimleri Bölümü, Tıp Eğitimi ve Bilişimi Anabilim Dalı | en_US |
dc.description | Makale (Early Access) | en_US |
dc.description | WOS:000926317400001 | en_US |
dc.description | PubMed ID:36745246 | en_US |
dc.description.abstract | Alzheimer's disease (AD) is accepted as a form of progressive dementia. Cholinergic systems are commonly affected in AD. Neurokinin 3 receptor (NK3R) is involved in learning memory-related processes. It is known that the activation of NK3R affects the release of many neurotransmitters. The aim of this project was to investigate the effects of NK3R agonist senktide administration on neurobehavioral mechanisms in the experimental AD-like rat model. 50 male Wistar albino rats were divided into Control (C), AD, Control + NK3R agonist (CS), AD + NK3R agonist (ADS), AD + NK3Ragonist + antagonist groups (ADSO). We designed AD-like model by intrahippocampal administration of A beta 1-42. After NK3R agonist + antagonist injections, open field (OF), Morris water maze (MWM) tests were applied. Cholinergic mechanism analysis from hippocampus-cortex tissues was performed by ELISA and catecholamine analysis from brain stem tissue were performed by HPLC method. The transitions from edge to center, rearing, grooming parameters were found to be reduced in final values of OF. While the group-time interaction was significant in the OF test findings, there was no significant difference between the groups. In MWM test, ADS group showed a learning level close to control group and animals in AD and ADSO groups could not learn target quadrant in MWM test. The brain stem NA and DA concentrations were not statistically significant. Hippocampal AChE-ChAT levels were supported by positive effects of senktide on learning via the cholinergic mechanisms. As a result, NK3R agonists were found to be effective in improving cognitive functions in rats with AD pathology. In the experimental AD model, positive effects of NK3R on learning memory may be mediated by cholinergic mechanisms. | en_US |
dc.description.sponsorship | Scientific Research Projects (BAP) Coordination Unit of Necmettin Erbakan University | en_US |
dc.identifier.citation | Özen Koca, R., Solak Görmüş, Z. I., Solak, H., Koç, A., Kılınç, İ., İyisoy, M. S., Kutlu, S. (2023). How does neurokinin 3 receptor agonism affect pathological and cognitive impairments in an Alzheimer's disease-like rat model. Amino Acids, 1-18. | en_US |
dc.identifier.doi | 10.1007/s00726-023-03241-0 | en_US |
dc.identifier.endpage | 18 | en_US |
dc.identifier.issn | 0939-4451 | en_US |
dc.identifier.issn | 1438-2199 | en_US |
dc.identifier.issue | - | en_US |
dc.identifier.pmid | 36745246 | en_US |
dc.identifier.scopusquality | Q2 | en_US |
dc.identifier.startpage | 1 | en_US |
dc.identifier.uri | http://dx.doi.org/10.1007/s00726-023-03241-0 | |
dc.identifier.uri | https://hdl.handle.net/20.500.12452/9391 | |
dc.identifier.volume | - | en_US |
dc.identifier.wos | WOS:000926317400001 | en_US |
dc.indekslendigikaynak | Web of Science | en_US |
dc.indekslendigikaynak | Scopus | en_US |
dc.indekslendigikaynak | PubMed | en_US |
dc.language.iso | en | en_US |
dc.publisher | Springer Wien | en_US |
dc.relation.ispartof | Amino Acids | en_US |
dc.relation.publicationcategory | Makale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanı | en_US |
dc.rights | info:eu-repo/semantics/embargoedAccess | en_US |
dc.subject | Alzheimer’s Disease | en_US |
dc.subject | Neurokinin 3 Receptor | en_US |
dc.subject | Learning and Memory | en_US |
dc.subject | Cholinergic Mechanism | en_US |
dc.subject | Catecholaminergic Mechanism | en_US |
dc.title | How does neurokinin 3 receptor agonism affect pathological and cognitive impairments in an Alzheimer's disease-like rat model? | en_US |
dc.type | Article | en_US |
Dosyalar
Orijinal paket
1 - 1 / 1
Küçük Resim Yok
- İsim:
- How does neurokinin 3 receptor agonism affect pathological and cognitive impairments in an Alzheimer's disease-like rat model.pdf
- Boyut:
- 2.37 MB
- Biçim:
- Adobe Portable Document Format
- Açıklama:
- Tam Metin (Full Text)
Lisans paketi
1 - 1 / 1
Küçük Resim Yok
- İsim:
- license.txt
- Boyut:
- 1.44 KB
- Biçim:
- Item-specific license agreed upon to submission
- Açıklama: